Clear cell sarcoma Is a rare tumor with a poor prognosis. The therapeutic approach in the metastatic disease stage is controversial: to the authors' knowledge the use of concurrent chemoimmunotherapy has not been previously reported. We present a case of a 57-year-old male with metastatic clear cell sarcoma treated simultaneously with subcutaneous interferon-a 2b and six courses of chemotherapy according to the CyVEDIC regimen. Disease stabilization lasting 17 months was achieved.
Concurrent chemoimmunotherapy in metastatic clear cell sarcoma: A case report / Lauro, Salvatore; F., Bordin; Trasatti, Luciana; G., Lanzetta; DELLA ROCCA, Carlo; Frati, Luigi. - In: TUMORI. - ISSN 0300-8916. - STAMPA. - 85:6(1999), pp. 512-514.
Concurrent chemoimmunotherapy in metastatic clear cell sarcoma: A case report
LAURO, Salvatore;TRASATTI, Luciana;DELLA ROCCA, Carlo;FRATI, Luigi
1999
Abstract
Clear cell sarcoma Is a rare tumor with a poor prognosis. The therapeutic approach in the metastatic disease stage is controversial: to the authors' knowledge the use of concurrent chemoimmunotherapy has not been previously reported. We present a case of a 57-year-old male with metastatic clear cell sarcoma treated simultaneously with subcutaneous interferon-a 2b and six courses of chemotherapy according to the CyVEDIC regimen. Disease stabilization lasting 17 months was achieved.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
